Resumen de acción BBBY.Q
Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Bed Bath & Beyond Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.079 |
| 52 Week High | US$7.03 |
| 52 Week Low | US$0.048 |
| Beta | 1.52 |
| 1 Month Change | -69.88% |
| 3 Month Change | -74.41% |
| 1 Year Change | -98.68% |
| 3 Year Change | -99.62% |
| 5 Year Change | -99.44% |
| Change since IPO | -92.57% |
Noticias y actualizaciones recientes
Recent updates
Bed Bath & Beyond: Potential Acceleration Of Largest Debt Tranche Could Cause Liquidity Crisis
Oct 13Bed Bath & Beyond Even Less Compelling Now
Sep 26Bed Bath & Beyond lists first 56 stores slated for closure
Sep 15Bed Bath & Beyond slides on proposed stock offering
Aug 31Bed Bath & Beyond: Beyond Reorganization
Aug 23Bed Bath & Beyond: Massive Short Squeeze Could Be Coming Soon
Aug 16Bed Bath & Beyond: To The Moon Again
Aug 10Bed Bath & Beyond's (NASDAQ:BBBY) Short Squeeze may be Risky, but the New Business Model has a Chance
Aug 08
Bed Bath & Beyond: Inflation Is Its Best Friend
Jul 30Bed Bath & Beyond: This Time It's Different
Jul 05Bed Bath & Beyond Inc. (NASDAQ:BBBY) Analysts Just Cut Their EPS Forecasts Substantially
Jun 30Bed Bath & Beyond Non-GAAP EPS of -$2.83 misses by $1.44, revenue of $1.46B misses by $50M
Jun 29Bed Bath & Beyond: A Shot At Survival
Jun 13Bed Bath & Beyond: Declining Sales And Contracting Margins
May 27Bed Bath & Beyond Q4 Earnings: Ouch, But There Is A Silver Lining
Apr 13Bed Bath & Beyond: Evaluating The Prospects Amid The Meme Stock Mania Comeback
Mar 29Analyzing Insider Transactions can Unlock More Opportunities like Bed Bath & Beyond (NASDAQ:BBBY)
Mar 08Bed Bath & Beyond: Insider Activity Has Me Intrigued
Feb 03Bed Bath & Beyond: On The J. C. Penney Road To Ruin
Dec 08Rentabilidad de los accionistas
| BBBY.Q | US Specialty Retail | Mercado US | |
|---|---|---|---|
| 7D | -43.6% | 2.6% | 2.0% |
| 1Y | -98.7% | 12.2% | 22.3% |
Rentabilidad vs. Industria: BBBY.Q obtuvo unos resultados inferiores a los del sector US Specialty Retail , que el año pasado arrojó un rendimiento del 12.2%.
Rentabilidad vs. Mercado: BBBY.Q obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| BBBY.Q volatility | |
|---|---|
| BBBY.Q Average Weekly Movement | 32.7% |
| Specialty Retail Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de BBBY.Q ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de BBBY.Q(33%) se ha mantenido estable durante el último año, pero sigue siendo superior al 75% de las acciones de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1971 | 20,000 | Sue Gove | www.bedbathandbeyond.com |
Resumen de fundamentos de Bed Bath & Beyond Inc.
| Estadísticas fundamentales de BBBY.Q | |
|---|---|
| Capitalización bursátil | US$61.66m |
| Beneficios(TTM) | -US$3.50b |
| Ingresos (TTM) | US$5.34b |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está BBBY.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de BBBY.Q | |
|---|---|
| Ingresos | US$5.34b |
| Coste de los ingresos | US$4.13b |
| Beneficio bruto | US$1.21b |
| Otros gastos | US$4.71b |
| Beneficios | -US$3.50b |
Últimos beneficios comunicados
Feb 25, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -4.48 |
| Margen bruto | 22.73% |
| Margen de beneficio neto | -65.46% |
| Ratio deuda/patrimonio | -60.4% |
¿Cómo se ha desempeñado BBBY.Q a largo plazo?
Ver rendimiento histórico y comparativa